TE
科技回声
首页24小时热榜最新最佳问答展示工作
GitHubTwitter
首页

科技回声

基于 Next.js 构建的科技新闻平台,提供全球科技新闻和讨论内容。

GitHubTwitter

首页

首页最新最佳问答展示工作

资源链接

HackerNews API原版 HackerNewsNext.js

© 2025 科技回声. 版权所有。

Eli Lilly caps the cost of insulin at $35 a month

24 点作者 indus大约 2 年前

3 条评论

projektfu大约 2 年前
Apparently they already had a discount card program but it may have been hard to access. The new program automatically applies for Medicare and many commercial insurance.<p>They are also reducing the list price of generic insulin lispro, Humalog, and Humulin insulin and mixtures, but they&#x27;ll still be pretty expensive at list price.<p>But most interesting to me, they&#x27;re introducing an insulin glargine-aglr pen at 5 pk for $92 list price. Basaglar (Lilly&#x27;s own glargine) is $326. Lantus is around $500. The glargine-aglr is supposed to be bioequivalent in humans, we&#x27;ll have to see from experience if that&#x27;s true for cats.
olliej大约 2 年前
So basically in response to legislation, presumably to head off stricter legislation they&#x27;ve come up with a program to allow people to only pay $35&#x2F;month. They&#x27;re not lowering or capping the price, they&#x27;re introducing a program modeled after their other systems in which they claim the price is only $X but if you ever mess up, or if you don&#x27;t know about this magic program, or if you don&#x27;t continuously ensure you&#x27;re still following the terms of the program your price spikes again.<p>That they aren&#x27;t actually lowering the price means that they very clearly have no intention of making this &quot;discount&quot; program actually usable.<p>The only reason for this program is to allow them to claim they are not maliciously price gouging in order to avoid legislation actually mandating they comply with existing anti-price gouging and anti-monopoly laws until they can buy some new congress people and senators, and then just ramp up the difficulty in applying for the discount.<p>This is not new behaviour: every one of the big pharmaceuticals has had medications that they have made &quot;cheap&quot; on a program, and then made the program not apply anymore once changing to an alternative is no longer reasonable.<p>Just as the CEO of Pfizer and Moderna demonstrated with the &gt;$100 per $1 vaccine shot: they want to charge the market &quot;value&quot; of being alive for absolutely anything they have the opportunity to, which is definitionally price gouging. The management of these companies is pathologically opposed to any ethical pricing model. My proposal: any drug that they or their family or their friends ever needs must be priced - for them - such that they are left with only just enough assets and cashflow to afford 2 weeks of planned expenses, including any income or assets in trust funds or in other family&#x2F;friend&#x27;s name.
legitster大约 2 年前
&gt; In November, Eli Lilly’s stock price dropped sharply after a fake tweet from an imposter account falsely claimed that the company was making insulin free, renewing focus on its cost.<p>I wish this wasn&#x27;t getting regurgitated as fact. The entire market dipped that day. A joke tweet probably had nothing to do with it.
评论 #34991472 未加载